Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

2.

Pharmacologic treatment of type 2 diabetic dyslipidemia.

Moon YS, Kashyap ML.

Pharmacotherapy. 2004 Dec;24(12):1692-713. Review.

PMID:
15585439
3.
4.

Insulin therapy in children and adolescents.

Tamborlane WV, Sikes KA.

Endocrinol Metab Clin North Am. 2012 Mar;41(1):145-60. doi: 10.1016/j.ecl.2012.01.002. Epub 2012 Feb 24. Review.

PMID:
22575411
7.

Insulin resistance as a physiological defense against metabolic stress: implications for the management of subsets of type 2 diabetes.

Nolan CJ, Ruderman NB, Kahn SE, Pedersen O, Prentki M.

Diabetes. 2015 Mar;64(3):673-86. doi: 10.2337/db14-0694. Review.

8.

Factors impeding the discovery of an intervention-based treatment for type 1 diabetes.

von Herrath MG, Korsgren O, Atkinson MA.

Clin Exp Immunol. 2016 Jan;183(1):1-7. doi: 10.1111/cei.12656. Epub 2015 Jul 24. Review.

9.

[Insulin and its place in the therapy of diabetes mellitus types 1 and 2].

Balabolkin MI.

Probl Endokrinol (Mosk). 1990 Jul-Aug;36(4):63-9. Review. Russian. No abstract available.

PMID:
2235935
10.

Future therapies.

Bailey CJ, Day C.

Curr Med Res Opin. 2002;18 Suppl 1:s82-8. Review.

PMID:
12365822
11.

Can we prevent type 1 diabetes?

Beauchamp G, Haller MJ.

Curr Diab Rep. 2015 Nov;15(11):86. doi: 10.1007/s11892-015-0658-6. Review.

PMID:
26370697
12.

Therapeutic Effect of Cereal Grains: A Review.

Singhal P, Kaushik G.

Crit Rev Food Sci Nutr. 2016;56(5):748-59. doi: 10.1080/10408398.2012.714417. Review.

PMID:
25746052
13.

Metabolomics in childhood diabetes.

Frohnert BI, Rewers MJ.

Pediatr Diabetes. 2016 Feb;17(1):3-14. doi: 10.1111/pedi.12323. Epub 2015 Sep 30. Review.

14.

Management of Severe Insulin Resistance in Patients with Type 1 Diabetes.

Schechter R, Reutrakul S.

Curr Diab Rep. 2015 Oct;15(10):77. doi: 10.1007/s11892-015-0641-2. Review.

PMID:
26294334
15.

iNKT and MAIT Cell Alterations in Diabetes.

Magalhaes I, Kiaf B, Lehuen A.

Front Immunol. 2015 Jul 2;6:341. doi: 10.3389/fimmu.2015.00341. eCollection 2015. Review.

16.

Cardiac autoimmunity as a novel biomarker, mediator, and therapeutic target of heart disease in type 1 diabetes.

Lipes MA, Galderisi A.

Curr Diab Rep. 2015 May;15(5):30. doi: 10.1007/s11892-015-0598-1. Review.

17.

Disease modifying therapies in type 1 diabetes: Where have we been, and where are we going?

Lord S, Greenbaum CJ.

Pharmacol Res. 2015 Aug;98:3-8. doi: 10.1016/j.phrs.2015.02.002. Epub 2015 Mar 11. Review.

18.

Immunomodulation by helminths: Similar impact on type 1 and type 2 diabetes?

Surendar J, Indulekha K, Hoerauf A, Hübner MP.

Parasite Immunol. 2017 May;39(5). doi: 10.1111/pim.12401. Epub 2016 Dec 15. Review.

PMID:
27862000

Supplemental Content

Support Center